Meridian Medica

01

Identity

Botanical Profile

Fraxinus americana L. / F. excelsior L. — Bark (inner bark, young branch bark); leaves; seeds (keys). F. americana (White Ash) native to eastern North America; F. excelsior (European or Common Ash) native to Europe and western Asia. Both species are large deciduous trees of forest edges, floodplains, and rich soils.

Inner bark: bitter, slightly astringent, mildly aromatic. Dried bark is grayish-brown, with characteristic diamond-patterned (F. americana) or corky-ridged (F. excelsior) outer bark. Taste is bitter with a mild tannic quality. Leaves: slightly bitter, astringent. Seeds (ash keys): bitter-aromatic, lightly pungent.

Species Integrity

F. americana and F. excelsior are closely related and traditionally interchangeable for herbal use. F. excelsior is the primary species in European phytomedicine (German Commission E); F. americana in North American Eclectic and Native traditions.

02

Compounds

Active Compound Profile

Secoiridoid glycosides (oleuropein, ligstroside, nuzhenide)

0.5–2.5% dry weight in bark and leaves

Anti-inflammatory via COX-2 and NF-κB inhibition; antioxidant; mild hypoglycemic; antihypertensive via ACE inhibition; bitter tonic

Fraxin / Fraxetin (coumarins)

0.3–1.5% in bark

Anti-inflammatory; mild diuretic; urinary anti-spasmodic; antioxidant; mild anticoagulant at high doses

Mannitol (in bark and manna ash, F. ornus)

5–20% in manna ash (F. ornus) sap; trace in other species

Osmotic laxative; prebiotic activity at lower doses; anti-inflammatory

Tannins (gallic acid, condensed tannins)

2–8% in bark

Astringent; antimicrobial; anti-inflammatory; protein precipitation at mucosal surfaces

Absorption

Decoction of bark: Secoiridoids, fraxin/fraxetin, and tannins all extract well into hot water with extended simmering; 20-minute decoction ensures complete extraction

03

Pathways

Mechanism of Action

★★★☆☆ Anti-Arthritic / Anti-Inflammatory Secoiridoids (oleuropein-related compounds) inhibit COX-2 and NF-κB, reducing prostaglandin and cytokine production; fraxetin provides additional anti-inflammatory activity via LOX inhibition

★★★☆☆ Diuretic / Uricosuric Fraxin and fraxetin promote renal water excretion (mild diuretic); traditional use for uric acid elimination and gout prevention aligns with diuretic and anti-inflammatory mechanisms

★★★☆☆ Hypoglycemic / Metabolic Support Secoiridoid glycosides demonstrate ACE inhibition and mild insulin-sensitizing activity in animal models; fraxetin shows mild glucose-lowering activity in vitro

★★★☆☆ Bitter Tonic / Digestive Secoiridoids are bitter principles that activate TAS2R receptors; contribute to digestive bitter tonic application of ash bark

04

Biomarkers

What It Moves in Your Labs

Biomarker	Direction	Target	Mechanism
Uric Acid (serum)	↓ Decrease	<6.0 mg/dL (women) / <7.0 mg/dL (men)	Diuretic and uricosuric traditional use; enhanced renal uric acid excretion
hs-CRP	↓ Decrease	<1.0 mg/L	Secoiridoid and fraxetin COX-2/NF-κB inhibition reduces systemic inflammatory marker production
Fasting Glucose	↓ Decrease	<100 mg/dL	Secoiridoid mild insulin-sensitizing and ACE inhibition effects; metabolic support in hypothyroid insulin resistance

05

Extraction

Extraction & Preparation

Decoction (bark or leaves, 20 min): Excellent for secoiridoids, fraxin, and tannins

Solubility · Water-soluble; also ethanol-solubleMenstruum · 50% ethanolPlant material · Dried inner bark or dried leaves (F. excelsior or F. americana)Maceration time · 4 weeks (agitate daily)Ratio · 1:5 dried

07

Dosing

Dosing Framework

Anti-rheumatic use: take with meals to improve tolerability of bitter secoiridoids; no restriction on timing relative to other herbs.

Dose 1

Tonic: 1–2 cups leaf tea or 2 mL tincture, 2x daily

Sustainable long-term use; traditional daily tonic dose

Dose 2

Therapeutic: 3 cups decoction or 4–5 mL tincture, 3x daily

German Commission E approved range; 4–8 week therapeutic course

Dose 3

Maintenance anti-gout: 2 cups leaf tea daily

Long-term prevention protocol; combine with low-purine dietary adjustments

08

Synergies

Synergy Partners

★★★☆☆ Meadowsweet (Filipendula ulmaria) Complementary anti-inflammatory mechanisms; meadowsweet's methyl salicylate COX-1/2 inhibition + ash's secoiridoid/fraxetin activity = synergistic anti-rheumatic combination without NSAID side effects

★★★☆☆ Celery Seed (Apium graveolens) Complementary uricosuric and diuretic action; celery seed's phthalides and flavonoids reduce uric acid production and enhance renal excretion

★★★☆☆ Devil's Claw (Harpagophytum procumbens) Harpagoside iridoids provide additional COX-2 and 5-LOX inhibition; complementary anti-inflammatory mechanism with clinical trial evidence for joint pain

★★★☆☆ Dandelion root/leaf (Taraxacum officinale) Synergistic diuretic and metabolic support; dandelion's potassium-sparing diuresis + liver support complement ash's diuretic and metabolic activity

Signature Stack

THE ANTI-RHEUMATIC TRIO
Components: Ash (bark/leaf) + Meadowsweet (aerial parts) + Celery Seed · Multi-pathway convergence: Secoiridoid anti-inflammatory (ash) + salicylate COX inhibition (meadowsweet) + uricosuric diuretic (celery seed) + mild anticoagulant (fraxetin) · This trio addresses the arthritis-gout-inflammation triad of hypothyroid musculoskeletal disease. Ash provides the bitter secoiridoid anti-inflammatory backbone, meadowsweet the aspirin-like COX inhibition, and celery seed the targeted uric acid and diuretic support. · Practical integration: Anti-Rheumatic Decoction; sustained 8–12 week protocols for joint and uric acid management; foundational musculoskeletal layer in the Meridian Medica protocol.

09

Safety

Contraindications & Interactions

Minor Anticoagulant medications Fraxetin has mild coumarin anticoagulant activity. Theoretical additive effect with warfarin and other anticoagulants at high doses.

Minor Kidney disease / reduced renal function Diuretic action of fraxin may increase renal load; use cautiously in patients with significantly reduced kidney function.

Minor Tannin-iron and medication binding Bark tannin content can reduce iron and medication absorption.

Minor Emerald Ash Borer conservation concern F. americana populations are critically threatened by Emerald Ash Borer. Wildcrafting from North American ash trees should be restricted to ethically sourced material from already-affected or managed trees.

11

Evidence

Evidence Base

★★★☆☆ Anti-Rheumatic / Anti-Inflammatory Moderate — German Commission E approval; secoiridoid mechanism confirmed in vitro; traditional use consistent

★★☆☆☆ Uricosuric / Anti-Gout Preliminary — Traditional use consistent; diuretic mechanism plausible; no clinical trials

★★☆☆☆ Diuretic Preliminary — In vivo animal data; traditional use; limited human trials

★★☆☆☆ Hypoglycemic / Metabolic Preliminary — In vitro and animal data; no human trials

Evidence Gaps

The highest priority research gap for Meridian Medica: Fraxinus bark and leaf have never been evaluated in a clinical trial for arthralgia or gout in hypothyroid patients, where uric acid mismanagement and musculoskeletal pain are highly prevalent comorbidities. A pilot study measuring serum uric acid, joint pain VAS scores, and inflammatory markers in Hashimoto's patients with arthralgias before and after 8 weeks of F. excelsior leaf tea would directly test this protocol application.

Quality Alert

Ash bark is not heavily adulterated but species confusion is common in commerce: F. americana, F. excelsior, and F. ornus (manna ash) have different chemistry. Ensure the species matches your therapeutic intent.

12

Protocol

Protocol Integration

Layer 1: Hypothalamic / Autonomic — HPA axis, circadian rhythm, stress response

Layer 2: Systemic Nutritional Repletion — Micronutrient optimization, antioxidant defense

Layer 3: Gut Permeability / Microbiome — Tight junction repair, motility, SIBO management

Recipe Integration

Anti-Rheumatic Decoction (signature preparation)

1 cup, 2–3x daily

Feed the Markers

Ash appears in the following Meridian Medica protocol contexts: